I read with interest the report by Zorlu et al. that effects on quality of life need addressing. The assessment appeared in the April 1994 issue of the Journal of Surgi-of response to new therapeutic modalities remains one cal Oncology on the use of second look laparotomy (SLL) area where SLL could
Second-look laparotomy
โ Scribed by James L Moore Jr.; James F. Barter
- Book ID
- 104594235
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 787 KB
- Volume
- 10
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
โฆ Synopsis
The second-look laparotomy has become an important means of assessing therapy response in ovarian cancer patients. This procedure enables the gynecologic oncologist to diligently search for small volume persistent disease, which often escapes detection by less invasive means. Subsequent treatment, if required, may then be tailored to the initial biologic response to therapy. However. many patients with negative findings at second look will develop recurrent disease, dampening enthusiasm for the operation. Although controversial, this procedure remains the gold standard for the detection of disease status following chemotherapy for ovarian cancer. @ 1994 WiIey-Liss. Inc.
๐ SIMILAR VOLUMES
We report our experience with consolidative 32 P after second-look laparotomy. Forty-three patients received consolidative 32 P after platinum-based chemotherapy and a negative (39 patients, 91%) or positive (4 patients) second-look laparotomy. Thirtyone patients (72%) initially had stage III (30 pa